- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Post-COVID-19
Central Data Repository
Explore the Central Data Repository: Use the filters and keyword search box on the left to find relevant studies. As you refine your search, the map and study list will automatically update to reflect your selections. Selecting a study from the list will provide detailed information about the specific study in question. A full legend can be found here
{content}
Study list
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Outpatient clinic
- Intensive care unit
- SARS-CoV-2
- Acute COVID-19
- Blood sample
- Adults (18-64 years)
- General population
- People at high risk of STIs
- PrEP users
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- MVA-BN
- Adults (18-64 years)
- People at high risk of STIs
- Men who have sex with men
- Primary care
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- Monkeypox virus
- Mpox
- Sexually transmitted infection
- Blood sample
- PBMC
- Pharmacological intervention
- Vaccination
- JYNNEOS
- Dryvax
- Adults (18-64 years)
- People at high risk of STIs
- Men who have sex with men
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- MVA-BN
- General population
- Infants (<1 year)
- Hospital
- Emergency department
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Respiratory syncytial virus infection
- Influenza
- COVID-19
- Adults (18-64 years)
- Healthcare workers
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults (18-64 years)
- Hospital
- Primary care
- Non-hospital health centre
- Emergency department
- Long-term care facility
- SARS-CoV-2
- Post-COVID-19
- Blood sample
- Nasopharyngeal swab
- Elderly (≥65 years)
- Fragile population
- Hospital
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Remdesivir
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Vocal-based therapy
- Adults (18-64 years)
- General population
- Community
- SARS-CoV-2
- Post-COVID-19
- Colchicine
- Antihistamines
- Rivaroxaban
- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox
- Adults (18-64 years)
- General population
- Outpatient clinic
- Non-hospital health centre
- STD/STI clinic
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- MVA-BN
- Adults (18-64 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Acute COVID-19
- Blood sample
- Nasopharyngeal swab
- PBMC
- Serum
- Stool sample
- Whole blood
- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox
- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- MVA-BN
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Blood sample
- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults (18-64 years)
- General population
- Adolescents (12-17 years)
- Children (1-11 years)
- People at high risk of STIs
- Men who have sex with men
- Primary care
- Monkeypox virus
- Mpox
- Sexually transmitted infection
- Adults (18-64 years)
- General population
- Primary care
- Monkeypox virus
- Mpox
- General population
- Adolescents (12-17 years)
- Children (1-11 years)
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Antivirals
- Cidofovir